Suppr超能文献

异位甲状腺患者甲状腺球蛋白分泌的控制

Control of thyroglobulin secretion in patients with ectopic thyroid gland.

作者信息

Leger J, Tar A, Schlumberger M, Czernichow P

机构信息

Unité d'Endocrinologie Pédiatrique et Diabète, Hôpital des Enfants Malades, Paris, France.

出版信息

Pediatr Res. 1988 Mar;23(3):266-9. doi: 10.1203/00006450-198803000-00007.

Abstract

Serum thyroglobulin (Tg) measurements were performed in 17 children with congenital hypothyroidism due to an ectopic thyroid gland before therapy and during follow-up. Data were analysed in four periods according to duration of therapy and compared to results obtained in a group of 51 normal children aged 1 month to 6 yr. At diagnosis serum Tg was higher than the mean normal value measured at a similar age. We observed a rapid and parallel decrease of both Tg and thyroid-stimulating hormone during the early weeks of therapy. However, Tg was always detectable in the serum of treated (euthyroid) patients. After 34 months of therapy serum Tg was 11.4 +/- 1 ng/ml, a value significantly different (p less than 0.001) from that obtained in normal controls of similar age (23.5 +/- 3 ng/ml). In nine treated children aged more than 2 yr, thyroid-stimulating hormone and Tg were increased after a brief period of decreased L-thyroxine dosage. These data indicate that ectopic thyroid tissue does not involute during thyroxine therapy and, in response to elevations of serum thyroid-stimulating hormone, can be stimulated to secrete Tg.

摘要

对17例因异位甲状腺导致先天性甲状腺功能减退症的患儿在治疗前及随访期间进行了血清甲状腺球蛋白(Tg)测定。根据治疗时间将数据分为四个阶段进行分析,并与一组51名年龄在1个月至6岁的正常儿童的结果进行比较。在诊断时,血清Tg高于相同年龄组的正常平均值。我们观察到在治疗的最初几周内,Tg和促甲状腺激素均迅速且平行下降。然而,在接受治疗(甲状腺功能正常)的患者血清中总是可检测到Tg。治疗34个月后,血清Tg为11.4±1 ng/ml,该值与相同年龄正常对照组(23.5±3 ng/ml)的结果有显著差异(p<0.001)。在9例年龄超过2岁的接受治疗的患儿中,在短暂降低左甲状腺素剂量后,促甲状腺激素和Tg升高。这些数据表明,异位甲状腺组织在甲状腺素治疗期间不会退化,并且在血清促甲状腺激素升高时可被刺激分泌Tg。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验